Growing community of inventors

Berlin, Germany

Tim Wesser

Average Co-Inventor Count = 6.46

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 1

Tim WesserRobert Fischer (2 patents)Tim WesserAnne Konkel (2 patents)Tim WesserJohn Russell Falck (1 patent)Tim WesserWolf-Hagen Schunck (1 patent)Tim WesserPhilipp Westphal (1 patent)Tim WesserWolf-Hagen Schunk (1 patent)Tim WesserChristina Westphal (1 patent)Tim WesserJanine Lossie (1 patent)Tim WesserDominik Müller (1 patent)Tim WesserJohn Russel Falck (1 patent)Tim WesserPhilipp Westphal (1 patent)Tim WesserDominik Muller (1 patent)Tim WesserJohn Russel Falck (0 patent)Tim WesserRobert Fischer (1 patent)Tim WesserTim Wesser (2 patents)Robert FischerRobert Fischer (7 patents)Anne KonkelAnne Konkel (3 patents)John Russell FalckJohn Russell Falck (34 patents)Wolf-Hagen SchunckWolf-Hagen Schunck (5 patents)Philipp WestphalPhilipp Westphal (1 patent)Wolf-Hagen SchunkWolf-Hagen Schunk (1 patent)Christina WestphalChristina Westphal (1 patent)Janine LossieJanine Lossie (1 patent)Dominik MüllerDominik Müller (1 patent)John Russel FalckJohn Russel Falck (1 patent)Philipp WestphalPhilipp Westphal (1 patent)Dominik MullerDominik Muller (3 patents)John Russel FalckJohn Russel Falck (0 patent)Robert FischerRobert Fischer (3 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Max-Delbruck-Centrum Fur Molekulare Medizin (2 from 31 patents)

2. Omeicos Therapeutics Gmbh (2 from 2 patents)

3. The University of Texas System (1 from 5,463 patents)

4. Max-Delbruck-Centrum Fur Molekulare Medizin in Der Helmholtz-Gemeinschaft (21 patents)


2 patents:

1. 12370158 - Analogs of CYP-eicosanoids for use in treating or preventing a disorder associated with neovascularization and/or inflammation

2. 11096910 - Metabolically robust analogs of CYP-eicosanoids for the treatment of cardiac disease

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/13/2026
Loading…